Products for Research Use Only

αGalCer-RBD

CAT: 0931-T74326-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T74326-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Target
Others, SARS-CoV
Related Pathways
Microbiology/Virology, Others
Bioactivity
αGalCer-RBD, a conjugate of the potent invariant natural killer T cell (iNKT) agonist α-Galactosylceramide (αGalCer) and the receptor-binding domain (RBD), serves as a self-adjuvanting lipoprotein that exhibits strong potential as a COVID-19 vaccine candidate. This compound effectively induces immunity against SARS-CoV-2 and its variants of concern by promoting the development of RBD-specific, cytokine-producing T cells.
Molecular Formula
C60H118N4O14
Molecular Weight
1119.6
Shipping Conditions
Ice Packs
Storage Temperature
-20°C